Insider Transactions in Q4 2022 at Bridge Bio Pharma, Inc. (BBIO)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2022
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
200,000
-16.73%
|
-
|
|
Nov 17
2022
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Open market or private sale
|
Direct |
19,678
-5.45%
|
$177,102
$9.4 P/Share
|
|
Nov 17
2022
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
34,640
-0.71%
|
$311,760
$9.4 P/Share
|
|
Nov 16
2022
|
Charles J Homcy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,301
-0.11%
|
$11,709
$9.64 P/Share
|
|
Nov 16
2022
|
Charles J Homcy |
BUY
Exercise of conversion of derivative security
|
Direct |
3,760
+0.31%
|
-
|
|
Nov 16
2022
|
Richard H Scheller Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,106
-2.09%
|
$9,954
$9.64 P/Share
|
|
Nov 16
2022
|
Richard H Scheller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,196
+5.68%
|
-
|
|
Nov 16
2022
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,789
-2.9%
|
$97,101
$9.64 P/Share
|
|
Nov 16
2022
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,467
+7.58%
|
-
|
|
Nov 16
2022
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
34,066
-0.7%
|
$306,594
$9.64 P/Share
|
|
Nov 16
2022
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,706
+1.39%
|
-
|